BCL6 expression correlates with the t(1;19) translocation in B-Lymphoblastic Leukemia

American Journal of Clinical Pathology

Volumn 143, Issue 4, 2015, Pages 547-557

  Deucher, Anne M ^a   Qi, Zhongxia ^a   Yu, Jingwei ^a   George, Tracy I ^b   Etzell, Joan E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

B ALL; B lymphoblastic leukemia; BCL6; T(1; 19); TCF3(E2A) PBX1

Indexed keywords

MESSENGER RNA; PARAFFIN; PROTEIN BCL 6; BCL6 PROTEIN, HUMAN; DNA BINDING PROTEIN; ONCOPROTEIN; TCF3-PBX1 FUSION PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LEUKEMIA; B LYMPHOBLASTIC LEUKEMIA; BONE MARROW; CHILD; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; INTERPHASE; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; VERY ELDERLY; YOUNG ADULT; ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL; B LYMPHOCYTE; CHROMOSOME 1; CHROMOSOME 19; GENE TRANSLOCATION; GENETICS; METABOLISM; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 84930326730     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPO4U4VYAAOTEL     Document Type: Article

References (41)

1. Li S, Lew G. Is B-lineage acute lymphoblastic leukemia with a mature phenotype and l1 morphology a precursor B-lymphoblastic leukemia/lymphoma or Burkitt leukemia/lymphoma? Arch Pathol Lab Med. 2003;127:1340-1344.
2. Borowitz M, Chan J. B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities. In: Swerdlow S, Campo E, Harris N, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008:171.
3. Al Gwaiz LA, Bassioni W. Immunophenotyping of acute lymphoblastic leukemia using immunohistochemistry in bone marrow biopsy specimens. Histol Histopathol. 2008;23:1223-1228.
4. Borowitz MJ, Chan JKC B lymphoblastic leukemia/lymphoma. In: Swerdlow S, Campo E, Harris N, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008:168.
5. Lundin C, Heldrup J, Ahlgren T, et al. B-cell precursor t(8;14)(q11;q32)-positive acute lymphoblastic leukemia in children is strongly associated with down syndrome or with a concomitant Philadelphia chromosome. Eur J Haematol. 2009;82:46-53.
6. Moorman AV, Harrison CJ, Buck GA, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood. 2007;109:3189-3197.
7. Haralambieva E, Boerma EJ, van Imhoff GW, et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol. 2005;29:1086-1094.
8. Hojo H, Sasaki Y, Nakamura N, et al. Absence of somatic hypermutation of immunoglobulin heavy chain variable region genes in precursor B-lymphoblastic lymphoma: a study of four cases in childhood and adolescence. Am J Clin Pathol. 2001;116:673-682.
9. Geng H, Brennan S, Milne TA, et al. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia. Cancer Discov. 2012;2:1004-1023.
10. Shaffer AL, Yu X, He Y, et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 2000;13:199-212.
11. Parekh S, Polo JM, Shaknovich R, et al. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. Blood. 2007;110:2067-2074.
12. Batlle A, Papadopoulou V, Gomes AR, et al. CD40 and B-cell receptor signalling induce MAPK family members that can either induce or repress bcl-6 expression. Mol Immunol. 2009;46:1727-1735.
13. Duy C, Yu JJ, Nahar R, et al. BCL6 is critical for the development of a diverse primary B cell repertoire. J Exp Med. 2010;207:1209-1221.
14. Nahar R, Ramezani-Rad P, Mossner M, et al. Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood. 2011;118:4174-4178.
15. Onizuka T, Moriyama M, Yamochi T, et al. BCL-6 gene product, a 92-to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood. 1995;86:28-37.
16. Falini B, Mason DY. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry. Blood. 2002;99:409-426.
17. Cerchietti LC, Yang SN, Shaknovich R, et al. A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo. Blood. 2009;113:3397-3405.
18. Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A. 1998;95:11816-11821.
19. Natkunam Y, Zhao S, Mason DY, et al. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood. 2007;109:1636-1642.
20. Natkunam Y, Lossos IS, Taidi B, et al. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood. 2005;105:3979-3986.
21. Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6:1-6.
22. Ross ME, Zhou X, Song G, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood. 2003;102:2951-2959.
23. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1:133-143.
24. Grimaldi JC, Meeker TC. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. Blood. 1989;73:2081-2085.
25. Borowitz MJ, Hunger SP, Carroll AJ, et al. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study. Blood. 1993;82:1086-1091.
26. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1:133-143.
27. Garg R, Kantarjian H, Thomas D, et al. Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy. Cancer. 2009;115:2147-2154.
28. Pui CH, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood. 1990;76:1449-1463.
29. Privitera E, Kamps MP, Hayashi Y, et al. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood. 1992;79:1781-1788.
30. Hunger SP, Sun T, Boswell AF, et al. Hyperdiploidy and E2A-PBX1 fusion in an adult with t(1;19)+ acute lymphoblastic leukemia: case report and review of the literature. Genes Chromosomes Cancer. 1997;20:392-398.
31. Carroll AJ, Crist WM, Parmley RT, et al. Pre-B cell leukemia associated with chromosome translocation 1;19. Blood. 1984;63:721-724.
32. Lu Q, Kamps MP. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specificities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain - demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo. Oncogene. 1997;14:75-83.
33. LeBrun DP, Cleary ML. Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1;19) leukemias. Oncogene. 1994;9:1641-1647.
34. Massari ME, Grant PA, Pray-Grant MG, et al. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol Cell. 1999;4:63-73.
35. Scheele JS, Kolanczyk M, Gantert M, et al. The spt-ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1. Leuk Lymphoma. 2009;50:816-828.
36. LeBrun DP, Matthews BP, Feldman BJ, et al. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains. Oncogene. 1997;15:2059-2067.
37. Shao YY, Wang L, Hicks DG, et al. Analysis of gene expression in mineralized skeletal tissues by laser capture microdissection and RT-PCR. Lab Invest. 2006;86:1089-1095.
38. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9:166-180.
39. Papadopoulou V, Postigo A, Sanchez-Tillo E, et al. ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locus. Biochem J. 2010;427:541-550.
40. Hunger SP Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood. 1996;87:1211-1224.
41. Sanz E, Munoz AN, Monserrat J, et al. Ordering human CD34+CD10-CD19+ pre/pro-B-cell and CD19-common lymphoid progenitor stages in two pro-B-cell development pathways. Proc Natl Acad Sci USA. 2010;107:5925-5930.